$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
卡博替尼可用于索拉非尼耐药的肝癌患者
2025-10-19 11:44:20
Check Details
瑞格非尼治疗肝癌的效果如何?
2025-10-19 11:44:20
Check Details
卡博替尼延长晚期肝癌总生存期
2025-10-19 11:44:20
Check Details
仑伐替尼显著延长肝癌患者的总生存
2025-10-19 11:44:20
Check Details
乐伐替尼-肝癌一线治疗药物
2025-10-19 11:44:20
Check Details
多吉美治疗晚期肝癌延长患者中位总生存期
2025-10-19 11:44:20
Check Details
乐伐替尼治疗HBV相关肝癌的有效性优于索拉非尼
2025-10-19 11:44:20
Check Details
卡博替尼治疗肝癌的效果
2025-10-19 11:44:20
Check Details
卡博替尼治疗肝癌
2025-10-19 11:44:20
Check Details
瑞格非尼(瑞戈非尼)治疗肝癌的疗效
2025-10-19 11:44:20
Check Details
肝癌靶向药物乐伐替尼与索拉非尼临床数据
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗多吉美耐药的肝癌患者
2025-10-19 11:44:20
Check Details
1
2
...
2570
2571
2572
2573
2574
2575
2576
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
2
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
3
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
4
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
5
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
6
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
7
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
8
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
9
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
10
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
11
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
12
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?